News & Updates

Show Multimedia Only

First-line sacituzumab govitecan ups PFS in metastatic TBNC

07 Nov 2025 by

First-line treatment with sacituzumab govitecan, an antibody drug conjugate, significantly improved progression-free survival (PFS) compared with chemotherapy in patients with metastatic triple-negative breast cancer (TNBC), according to the ASCENT-03 trial presented at ESMO 2025.

First-line sacituzumab govitecan ups PFS in metastatic TBNC

07 Nov 2025

Endometriosis risk reduced with modest intake of soy products

05 Nov 2025

New research suggests that incorporating even modest amounts of soy into the diet may provide a protective benefit against endometriosis in women.

Endometriosis risk reduced with modest intake of soy products

05 Nov 2025

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

Adverse pregnancy outcomes put women at risk of AF

30 Oct 2025 by

Women with a history of preterm delivery, hypertensive disorders of pregnancy, and several other pregnancy complications face an increased long-term risk of atrial fibrillation (AF), as suggested in a study.

Adverse pregnancy outcomes put women at risk of AF

30 Oct 2025

ICON8B OS data support a new SoC for epithelial ovarian cancer

29 Oct 2025 by

In the final overall survival (OS) analysis of the phase III ICON8B trial, first-line treatment with bevacizumab in combination with a chemotherapeutic regimen comprising carboplatin Q3W and dose-dense paclitaxel QW improved survival in women with high-risk stage III-IV epithelial ovarian cancer.

ICON8B OS data support a new SoC for epithelial ovarian cancer

29 Oct 2025

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Ovarian hormone suppression gets rid of symptom cyclicity in women with premenstrual dysphoric disorder (PMDD), reports a study. In addition, ovarian steroid addback results in the emergence of symptoms in those with PMDD but not in healthy comparison women.

Ovarian steroid addback increases symptom severity in women with PMDD

27 Oct 2025

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Women with gestational diabetes are at heightened risks of overall and specific cardiovascular diseases (CVDs), including chronic hypertension, according to a nationwide population‐based cohort study.

Gestational diabetes tied to increased CVD risks

26 Oct 2025

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025 by

A retrospective analysis shows the potential of the 313-SNP breast cancer (BC) polygenic risk score (PRS313) blood test to predict future in situ or invasive breast disease in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025

Severe menopausal symptoms compromise work-related outcomes

19 Oct 2025

Women with severe menopausal symptoms appear to experience reduced work capacity and adverse work-related outcomes, as suggested in a recent cross-sectional study.

Severe menopausal symptoms compromise work-related outcomes

19 Oct 2025

Antioxidant supplementation in men seeking fertility care does not improve pregnancy rates

08 Oct 2025

The use of antioxidant supplements in men seeking fertility care does not appear to increase the chances of conceiving for their female partners, as shown in the multicentre SUMMER trial.

Antioxidant supplementation in men seeking fertility care does not improve pregnancy rates

08 Oct 2025

News & Updates

Filter by Specialty:

Specialty:

First-line sacituzumab govitecan ups PFS in metastatic TBNC

First-line sacituzumab govitecan ups PFS in metastatic TBNC

Endometriosis risk reduced with modest intake of soy products

Endometriosis risk reduced with modest intake of soy products

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Adverse pregnancy outcomes put women at risk of AF

Adverse pregnancy outcomes put women at risk of AF

ICON8B OS data support a new SoC for epithelial ovarian cancer

ICON8B OS data support a new SoC for epithelial ovarian cancer

Ovarian steroid addback increases symptom severity in women with PMDD

Ovarian steroid addback increases symptom severity in women with PMDD

Gestational diabetes tied to increased CVD risks

Gestational diabetes tied to increased CVD risks

Polygenic risk score shows promise in predicting future breast cancer events

Polygenic risk score shows promise in predicting future breast cancer events

Severe menopausal symptoms compromise work-related outcomes

Severe menopausal symptoms compromise work-related outcomes

Antioxidant supplementation in men seeking fertility care does not improve pregnancy rates

Antioxidant supplementation in men seeking fertility care does not improve pregnancy rates